ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
American Board of Internal Medicine shared a post on LinkedIn:
” Attention all oncologists.
ABIM will develop two new assessment options: a version of the Medical Oncology Longitudinal Knowledge Assessment (LKA®) that focuses on breast cancer and another that focuses on hematologic neoplasms with a target launch of these new LKAs in July 2026.
These new assessment options are the result of an evidence-based process through which extensive data were collected from the medical oncology community and analyzed to determine which focused areas would be most beneficial to the majority of oncologists.
Learn more about the new assessment options and what it could mean for you.”
“While today’s announcement is a step in the right direction to meet the learning needs of today’s busy, specialized oncologist, there’s a lot more to be done to improve the recertification process and resources, including expanding the scope of disease-focused LKAs.”
More posts featuring American Board of Internal Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023